Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter VI Diseases of the nervous system,FALLS,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,5,1.37 [1.12-1.67],0.0019641696115785,trans
Chapter VI Diseases of the nervous system,FALLS,VCAN,Versican core protein,Inverse variance weighted,5,1.3 [1.1-1.55],0.0025923302323613,trans
Chapter VI Diseases of the nervous system,FALLS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,5,1.29 [1.07-1.56],0.0072306827831908,trans
Chapter VI Diseases of the nervous system,FALLS,MMP7,Matrilysin,Inverse variance weighted,5,0.79 [0.65-0.95],0.0125767841902962,trans
Chapter VI Diseases of the nervous system,FALLS,REG1B,Lithostathine-1-beta,Inverse variance weighted,5,1.24 [1.03-1.49],0.0248582712129895,trans
Chapter VI Diseases of the nervous system,FALLS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,5,1.37 [1.04-1.8],0.0265633499931867,trans
Chapter VI Diseases of the nervous system,FALLS,FCRLB,Fc receptor-like B,Inverse variance weighted,5,0.84 [0.71-0.98],0.03059404660003,trans
Chapter VI Diseases of the nervous system,FALLS,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,5,1.24 [1.02-1.5],0.033007066983898,trans
Chapter VI Diseases of the nervous system,FALLS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,5,1.21 [1-1.46],0.0463177098883098,trans
Chapter VI Diseases of the nervous system,FALLS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,5,1.29 [1-1.66],0.0527695249499811,trans
Chapter VI Diseases of the nervous system,FALLS,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,5,1.19 [1-1.43],0.0540858002912662,trans
Chapter VI Diseases of the nervous system,FALLS,CDHR5,Cadherin-related family member 5,Inverse variance weighted,5,0.84 [0.7-1],0.054902990482396,trans
Chapter VI Diseases of the nervous system,FALLS,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,5,0.82 [0.67-1.01],0.057359803818222,trans
Chapter VI Diseases of the nervous system,FALLS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,5,1.2 [0.99-1.45],0.0694915621110746,trans
Chapter VI Diseases of the nervous system,FALLS,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,0.81 [0.64-1.02],0.0708448630778823,trans
Chapter VI Diseases of the nervous system,FALLS,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,5,0.84 [0.69-1.02],0.0787136687531802,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.78 [0.59-1.03],0.0789586031908416,trans
Chapter VI Diseases of the nervous system,FALLS,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,5,1.19 [0.98-1.45],0.0821950365072253,trans
Chapter VI Diseases of the nervous system,FALLS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,5,1.18 [0.98-1.43],0.0836782086877025,trans
Chapter VI Diseases of the nervous system,FALLS,RSPO1,R-spondin-1,Inverse variance weighted,5,1.29 [0.96-1.72],0.0858138471767439,trans
Chapter VI Diseases of the nervous system,FALLS,APOA2,Apolipoprotein A-II,Inverse variance weighted,5,1.19 [0.98-1.44],0.0859206266181098,trans
Chapter VI Diseases of the nervous system,FALLS,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,5,1.22 [0.97-1.52],0.0870740576011168,trans
Chapter VI Diseases of the nervous system,FALLS,CNTN5,Contactin-5,Inverse variance weighted,5,0.85 [0.69-1.03],0.0994695591721471,trans
Chapter VI Diseases of the nervous system,FALLS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.17 [0.97-1.41],0.101967774976503,trans
Chapter VI Diseases of the nervous system,FALLS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,5,1.14 [0.97-1.34],0.102224955073133,trans
Chapter VI Diseases of the nervous system,FALLS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,5,0.85 [0.69-1.04],0.105438677034311,trans
Chapter VI Diseases of the nervous system,FALLS,DDR1,Epithelial discoidin domain-containing receptor 1,Inverse variance weighted,5,0.86 [0.71-1.03],0.105617893447611,trans
Chapter VI Diseases of the nervous system,FALLS,MILR1,Allergin-1,Inverse variance weighted,5,1.17 [0.97-1.41],0.110741277056752,trans
Chapter VI Diseases of the nervous system,FALLS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,5,0.86 [0.71-1.04],0.111216774472384,trans
Chapter VI Diseases of the nervous system,FALLS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,5,0.86 [0.72-1.04],0.11399181076315,trans
Chapter VI Diseases of the nervous system,FALLS,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,5,0.82 [0.64-1.05],0.114140042499183,trans
Chapter VI Diseases of the nervous system,FALLS,ITGA2,Integrin alpha-2,Inverse variance weighted,5,0.87 [0.74-1.03],0.114562530390966,trans
Chapter VI Diseases of the nervous system,FALLS,C7,Complement component C7,Inverse variance weighted,5,0.86 [0.72-1.04],0.11566624578997,trans
Chapter VI Diseases of the nervous system,FALLS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,5,0.84 [0.67-1.04],0.116119904406027,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,5,0.86 [0.72-1.04],0.123414732627571,trans
Chapter VI Diseases of the nervous system,FALLS,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,5,1.17 [0.96-1.44],0.127497942417569,trans
Chapter VI Diseases of the nervous system,FALLS,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,5,1.15 [0.96-1.38],0.131139098538155,trans
Chapter VI Diseases of the nervous system,FALLS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,1.14 [0.96-1.36],0.134584000430078,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,5,1.14 [0.96-1.36],0.135380267308128,trans
Chapter VI Diseases of the nervous system,FALLS,FAM3C,Protein FAM3C,Inverse variance weighted,5,0.72 [0.46-1.11],0.137215044125924,trans
Chapter VI Diseases of the nervous system,FALLS,LGALS4,Galectin-4,Inverse variance weighted,5,1.15 [0.96-1.37],0.137615236753246,trans
Chapter VI Diseases of the nervous system,FALLS,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,5,1.12 [0.96-1.3],0.142113905181997,trans
Chapter VI Diseases of the nervous system,FALLS,PI3,Elafin,Inverse variance weighted,5,1.15 [0.95-1.38],0.142412409516652,trans
Chapter VI Diseases of the nervous system,FALLS,SERPINA11,Serpin A11,Inverse variance weighted,5,0.89 [0.77-1.04],0.142644457957547,trans
Chapter VI Diseases of the nervous system,FALLS,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.16 [0.95-1.43],0.148788692948909,trans
Chapter VI Diseases of the nervous system,FALLS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.15 [0.95-1.4],0.150469446861102,trans
Chapter VI Diseases of the nervous system,FALLS,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,5,0.87 [0.72-1.06],0.156295553686822,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,5,1.14 [0.95-1.38],0.160789215578226,trans
Chapter VI Diseases of the nervous system,FALLS,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,5,1.18 [0.93-1.5],0.162167712154866,trans
Chapter VI Diseases of the nervous system,FALLS,MATN3,Matrilin-3,Inverse variance weighted,5,1.13 [0.95-1.36],0.168582253237363,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,5,0.87 [0.72-1.06],0.178850557850337,trans
Chapter VI Diseases of the nervous system,FALLS,DTNB,Dystrobrevin beta,Inverse variance weighted,5,0.84 [0.65-1.08],0.182811764647989,trans
Chapter VI Diseases of the nervous system,FALLS,IL22,Interleukin-22,Inverse variance weighted,5,1.14 [0.94-1.38],0.188172722796981,trans
Chapter VI Diseases of the nervous system,FALLS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.88 [0.72-1.07],0.19067075368321,trans
Chapter VI Diseases of the nervous system,FALLS,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,5,1.13 [0.94-1.37],0.193152332825159,trans
Chapter VI Diseases of the nervous system,FALLS,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,5,0.86 [0.68-1.08],0.193580731036017,trans
Chapter VI Diseases of the nervous system,FALLS,CCL7,C-C motif chemokine 7,Inverse variance weighted,5,1.14 [0.94-1.38],0.195436379943809,trans
Chapter VI Diseases of the nervous system,FALLS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,5,1.13 [0.94-1.37],0.197598468536452,trans
Chapter VI Diseases of the nervous system,FALLS,NPPB,Natriuretic peptides B,Inverse variance weighted,5,1.14 [0.93-1.38],0.20013872218924,trans
Chapter VI Diseases of the nervous system,FALLS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,5,1.18 [0.92-1.51],0.201345372383464,trans
Chapter VI Diseases of the nervous system,FALLS,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,5,0.89 [0.75-1.06],0.201970446301045,trans
Chapter VI Diseases of the nervous system,FALLS,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,5,1.13 [0.94-1.36],0.204300966201052,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,5,1.13 [0.94-1.36],0.205160149046374,trans
Chapter VI Diseases of the nervous system,FALLS,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,5,0.84 [0.64-1.1],0.207258494702718,trans
Chapter VI Diseases of the nervous system,FALLS,GOLM2,Protein GOLM2,Inverse variance weighted,5,0.88 [0.73-1.07],0.213215155567393,trans
Chapter VI Diseases of the nervous system,FALLS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,5,1.18 [0.91-1.52],0.216778110365361,trans
Chapter VI Diseases of the nervous system,FALLS,PLXNB2,Plexin-B2,Inverse variance weighted,5,0.9 [0.77-1.06],0.217320917379013,trans
Chapter VI Diseases of the nervous system,FALLS,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.88 [0.72-1.08],0.218250649670558,trans
Chapter VI Diseases of the nervous system,FALLS,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,5,1.13 [0.93-1.38],0.221600359524109,trans
Chapter VI Diseases of the nervous system,FALLS,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,5,0.89 [0.74-1.07],0.222524667612285,trans
Chapter VI Diseases of the nervous system,FALLS,CTSV,Cathepsin L2,Inverse variance weighted,5,0.89 [0.74-1.07],0.224340669070077,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,5,0.89 [0.74-1.07],0.228090985023107,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.13 [0.93-1.37],0.228620457968394,trans
Chapter VI Diseases of the nervous system,FALLS,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,5,1.13 [0.93-1.37],0.233355216203056,trans
Chapter VI Diseases of the nervous system,FALLS,MSLN,Mesothelin,Inverse variance weighted,5,0.9 [0.75-1.07],0.237270060850615,trans
Chapter VI Diseases of the nervous system,FALLS,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.12 [0.93-1.35],0.242317785120765,trans
Chapter VI Diseases of the nervous system,FALLS,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,5,0.86 [0.66-1.12],0.249272022690532,trans
Chapter VI Diseases of the nervous system,FALLS,OSM,Oncostatin-M,Inverse variance weighted,5,1.12 [0.92-1.37],0.253360428255504,trans
Chapter VI Diseases of the nervous system,FALLS,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,5,0.9 [0.75-1.08],0.259155190547581,trans
Chapter VI Diseases of the nervous system,FALLS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,5,1.12 [0.92-1.36],0.261435072767129,trans
Chapter VI Diseases of the nervous system,FALLS,EGFR,Epidermal growth factor receptor,Inverse variance weighted,5,0.9 [0.74-1.09],0.263125370937404,trans
Chapter VI Diseases of the nervous system,FALLS,BCAN,Brevican core protein,Inverse variance weighted,5,1.18 [0.88-1.58],0.267497343655966,trans
Chapter VI Diseases of the nervous system,FALLS,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,5,1.11 [0.92-1.34],0.269004306054627,trans
Chapter VI Diseases of the nervous system,FALLS,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.12 [0.92-1.37],0.270184159532986,trans
Chapter VI Diseases of the nervous system,FALLS,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,5,0.89 [0.73-1.09],0.272566379603615,trans
Chapter VI Diseases of the nervous system,FALLS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,5,0.9 [0.74-1.09],0.276209127863347,trans
Chapter VI Diseases of the nervous system,FALLS,ITGAV,Integrin alpha-V,Inverse variance weighted,5,0.9 [0.75-1.09],0.280360676388822,trans
Chapter VI Diseases of the nervous system,FALLS,CCN4,CCN family member 4,Inverse variance weighted,5,1.11 [0.92-1.35],0.28213326942613,trans
Chapter VI Diseases of the nervous system,FALLS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,5,1.15 [0.89-1.47],0.283846965284484,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,5,1.1 [0.92-1.33],0.289131593739106,trans
Chapter VI Diseases of the nervous system,FALLS,PVR,Poliovirus receptor,Inverse variance weighted,5,0.92 [0.78-1.08],0.292770968955211,trans
Chapter VI Diseases of the nervous system,FALLS,MMP8,Neutrophil collagenase,Inverse variance weighted,5,1.11 [0.92-1.34],0.293397149494808,trans
Chapter VI Diseases of the nervous system,FALLS,CHGA,Chromogranin-A,Inverse variance weighted,5,1.11 [0.91-1.35],0.295634812311428,trans
Chapter VI Diseases of the nervous system,FALLS,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,5,0.9 [0.74-1.1],0.299643048084291,trans
Chapter VI Diseases of the nervous system,FALLS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,5,0.84 [0.61-1.17],0.307683588859806,trans
Chapter VI Diseases of the nervous system,FALLS,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,5,1.1 [0.91-1.34],0.31132136370224,trans
Chapter VI Diseases of the nervous system,FALLS,CD59,CD59 glycoprotein,Inverse variance weighted,5,1.1 [0.91-1.33],0.314014117178707,trans
Chapter VI Diseases of the nervous system,FALLS,ADIPOQ,Adiponectin,Inverse variance weighted,5,1.1 [0.91-1.34],0.3148198685908,trans
Chapter VI Diseases of the nervous system,FALLS,IL10,Interleukin-10,Inverse variance weighted,5,1.11 [0.91-1.36],0.320621369090019,trans
Chapter VI Diseases of the nervous system,FALLS,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.1 [0.91-1.34],0.322348707531633,trans
Chapter VI Diseases of the nervous system,FALLS,RNASET2,Ribonuclease T2,Inverse variance weighted,5,1.12 [0.89-1.4],0.323350584289043,trans
Chapter VI Diseases of the nervous system,FALLS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,5,0.91 [0.75-1.1],0.323914693815083,trans
Chapter VI Diseases of the nervous system,FALLS,GUCA2A,Guanylin,Inverse variance weighted,5,1.1 [0.91-1.34],0.324365746375758,trans
Chapter VI Diseases of the nervous system,FALLS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,5,1.1 [0.91-1.33],0.327740769240282,trans
Chapter VI Diseases of the nervous system,FALLS,F3,Tissue factor,Inverse variance weighted,5,0.91 [0.76-1.1],0.330621354329334,trans
Chapter VI Diseases of the nervous system,FALLS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,5,1.1 [0.91-1.33],0.341700869259787,trans
Chapter VI Diseases of the nervous system,FALLS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,5,1.1 [0.9-1.34],0.343321025721913,trans
Chapter VI Diseases of the nervous system,FALLS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,5,1.17 [0.84-1.61],0.348675853269675,trans
Chapter VI Diseases of the nervous system,FALLS,CTSL,Cathepsin L1,Inverse variance weighted,5,0.91 [0.75-1.11],0.353423672296572,trans
Chapter VI Diseases of the nervous system,FALLS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,5,1.09 [0.91-1.31],0.354733794015254,trans
Chapter VI Diseases of the nervous system,FALLS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,5,1.09 [0.91-1.3],0.357297316596674,trans
Chapter VI Diseases of the nervous system,FALLS,CX3CL1,Fractalkine,Inverse variance weighted,5,1.1 [0.9-1.33],0.358668843955447,trans
Chapter VI Diseases of the nervous system,FALLS,NEFL,Neurofilament light polypeptide,Inverse variance weighted,5,1.1 [0.9-1.34],0.358683253063278,trans
Chapter VI Diseases of the nervous system,FALLS,SELENOP,Selenoprotein P,Inverse variance weighted,5,1.1 [0.9-1.34],0.359514049125616,trans
Chapter VI Diseases of the nervous system,FALLS,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.87 [0.64-1.18],0.36195589473887,trans
Chapter VI Diseases of the nervous system,FALLS,CCN3,CCN family member 3,Inverse variance weighted,5,1.09 [0.91-1.3],0.362106706750493,trans
Chapter VI Diseases of the nervous system,FALLS,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,5,1.09 [0.9-1.33],0.368336151085323,trans
Chapter VI Diseases of the nervous system,FALLS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,5,1.09 [0.91-1.3],0.368471601698782,trans
Chapter VI Diseases of the nervous system,FALLS,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,5,0.91 [0.75-1.12],0.371822104473851,trans
Chapter VI Diseases of the nervous system,FALLS,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,5,0.92 [0.75-1.11],0.373462766783875,trans
Chapter VI Diseases of the nervous system,FALLS,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.09 [0.9-1.32],0.374783771021501,trans
Chapter VI Diseases of the nervous system,FALLS,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,5,1.1 [0.89-1.37],0.376305805925274,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,5,0.92 [0.75-1.11],0.380226895212939,trans
Chapter VI Diseases of the nervous system,FALLS,ANXA10,Annexin A10,Inverse variance weighted,5,1.09 [0.89-1.33],0.38912383424367,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,5,0.93 [0.78-1.1],0.390059278938076,trans
Chapter VI Diseases of the nervous system,FALLS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.09 [0.9-1.33],0.392392671439234,trans
Chapter VI Diseases of the nervous system,FALLS,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.09 [0.89-1.33],0.394389671618388,trans
Chapter VI Diseases of the nervous system,FALLS,ACTN2,Alpha-actinin-2,Inverse variance weighted,5,0.92 [0.75-1.12],0.399431384386029,trans
Chapter VI Diseases of the nervous system,FALLS,FAM3B,Protein FAM3B,Inverse variance weighted,5,1.08 [0.9-1.3],0.401495082439368,trans
Chapter VI Diseases of the nervous system,FALLS,AREG,Amphiregulin,Inverse variance weighted,5,0.92 [0.76-1.12],0.404630629456693,trans
Chapter VI Diseases of the nervous system,FALLS,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,5,0.93 [0.78-1.11],0.4096427439952,trans
Chapter VI Diseases of the nervous system,FALLS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.08 [0.9-1.31],0.410425316279943,trans
Chapter VI Diseases of the nervous system,FALLS,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,5,1.09 [0.89-1.32],0.41571282089668,trans
Chapter VI Diseases of the nervous system,FALLS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,5,0.9 [0.69-1.17],0.420227412958903,trans
Chapter VI Diseases of the nervous system,FALLS,ANGPT2,Angiopoietin-2,Inverse variance weighted,5,0.89 [0.68-1.17],0.420657918408928,trans
Chapter VI Diseases of the nervous system,FALLS,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,5,0.92 [0.76-1.12],0.420782704737424,trans
Chapter VI Diseases of the nervous system,FALLS,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,5,1.08 [0.89-1.32],0.423167075354445,trans
Chapter VI Diseases of the nervous system,FALLS,CFP,Properdin,Inverse variance weighted,5,0.93 [0.76-1.12],0.424728525692461,trans
Chapter VI Diseases of the nervous system,FALLS,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,5,0.92 [0.75-1.13],0.427831253618017,trans
Chapter VI Diseases of the nervous system,FALLS,LMNB2,Lamin-B2,Inverse variance weighted,5,1.08 [0.89-1.31],0.435330026412396,trans
Chapter VI Diseases of the nervous system,FALLS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,5,1.09 [0.88-1.35],0.435504244771647,trans
Chapter VI Diseases of the nervous system,FALLS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,5,0.88 [0.65-1.21],0.435643214573757,trans
Chapter VI Diseases of the nervous system,FALLS,CTSZ,Cathepsin Z,Inverse variance weighted,5,0.92 [0.75-1.14],0.444210233501157,trans
Chapter VI Diseases of the nervous system,FALLS,CD83,CD83 antigen,Inverse variance weighted,5,0.93 [0.76-1.13],0.449369849318558,trans
Chapter VI Diseases of the nervous system,FALLS,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,5,0.89 [0.67-1.19],0.450371261465045,trans
Chapter VI Diseases of the nervous system,FALLS,OCLN,Occludin,Inverse variance weighted,5,0.93 [0.77-1.13],0.450547653394892,trans
Chapter VI Diseases of the nervous system,FALLS,BCAM,Basal cell adhesion molecule,Inverse variance weighted,5,0.92 [0.74-1.15],0.464423406032928,trans
Chapter VI Diseases of the nervous system,FALLS,TNC,Tenascin,Inverse variance weighted,5,1.07 [0.89-1.29],0.468256870793975,trans
Chapter VI Diseases of the nervous system,FALLS,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,5,0.93 [0.78-1.12],0.469409922362145,trans
Chapter VI Diseases of the nervous system,FALLS,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,5,1.09 [0.87-1.36],0.470624980444879,trans
Chapter VI Diseases of the nervous system,FALLS,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,5,1.07 [0.89-1.29],0.472728840947704,trans
Chapter VI Diseases of the nervous system,FALLS,CCL21,C-C motif chemokine 21,Inverse variance weighted,5,1.08 [0.88-1.32],0.482377595371556,trans
Chapter VI Diseases of the nervous system,FALLS,EPO,Erythropoietin,Inverse variance weighted,5,1.07 [0.88-1.31],0.483739926074069,trans
Chapter VI Diseases of the nervous system,FALLS,CHAD,Chondroadherin,Inverse variance weighted,5,0.91 [0.71-1.18],0.484919278472375,trans
Chapter VI Diseases of the nervous system,FALLS,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,5,1.08 [0.87-1.33],0.484953192086695,trans
Chapter VI Diseases of the nervous system,FALLS,SCGN,Secretagogin,Inverse variance weighted,5,0.93 [0.76-1.14],0.487760906199794,trans
Chapter VI Diseases of the nervous system,FALLS,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,5,1.08 [0.87-1.33],0.488010623715374,trans
Chapter VI Diseases of the nervous system,FALLS,PDCD1,Programmed cell death protein 1,Inverse variance weighted,5,1.11 [0.82-1.49],0.491954875579067,trans
Chapter VI Diseases of the nervous system,FALLS,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,5,1.07 [0.88-1.31],0.494191472678843,trans
Chapter VI Diseases of the nervous system,FALLS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,5,1.07 [0.88-1.3],0.497462057640933,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,5,1.07 [0.88-1.29],0.4982084779744,trans
Chapter VI Diseases of the nervous system,FALLS,CCL14,C-C motif chemokine 14,Inverse variance weighted,5,1.07 [0.88-1.29],0.498243359375258,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,5,0.93 [0.76-1.14],0.499830622991166,trans
Chapter VI Diseases of the nervous system,FALLS,CHRDL1,Chordin-like protein 1,Inverse variance weighted,5,0.94 [0.79-1.12],0.500930703590958,trans
Chapter VI Diseases of the nervous system,FALLS,FOLR2,Folate receptor beta,Inverse variance weighted,5,0.94 [0.77-1.13],0.501194437822272,trans
Chapter VI Diseases of the nervous system,FALLS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,5,0.93 [0.77-1.14],0.505506961317744,trans
Chapter VI Diseases of the nervous system,FALLS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.09 [0.84-1.41],0.509366252689019,trans
Chapter VI Diseases of the nervous system,FALLS,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,5,0.91 [0.68-1.21],0.510358987863097,trans
Chapter VI Diseases of the nervous system,FALLS,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,5,0.94 [0.77-1.14],0.510392694441849,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,5,0.92 [0.73-1.17],0.514687343846374,trans
Chapter VI Diseases of the nervous system,FALLS,MMP3,Stromelysin-1,Inverse variance weighted,5,1.05 [0.91-1.21],0.515871737599196,trans
Chapter VI Diseases of the nervous system,FALLS,CD276,CD276 antigen,Inverse variance weighted,5,0.93 [0.75-1.16],0.517529857193328,trans
Chapter VI Diseases of the nervous system,FALLS,ITGAM,Integrin alpha-M,Inverse variance weighted,5,0.93 [0.75-1.16],0.517742319870469,trans
Chapter VI Diseases of the nervous system,FALLS,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,5,1.06 [0.88-1.27],0.525080613354016,trans
Chapter VI Diseases of the nervous system,FALLS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,5,1.06 [0.88-1.29],0.530216050762468,trans
Chapter VI Diseases of the nervous system,FALLS,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,5,0.91 [0.69-1.21],0.530961404015463,trans
Chapter VI Diseases of the nervous system,FALLS,CCL25,C-C motif chemokine 25,Inverse variance weighted,5,1.05 [0.9-1.23],0.533759238840984,trans
Chapter VI Diseases of the nervous system,FALLS,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,5,0.94 [0.78-1.14],0.533885644799778,trans
Chapter VI Diseases of the nervous system,FALLS,WNT9A,Protein Wnt-9a,Inverse variance weighted,5,1.1 [0.8-1.52],0.542566368331654,trans
Chapter VI Diseases of the nervous system,FALLS,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.91 [0.66-1.25],0.550219208735164,trans
Chapter VI Diseases of the nervous system,FALLS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,5,0.93 [0.74-1.17],0.551635978272103,trans
Chapter VI Diseases of the nervous system,FALLS,EFNA4,Ephrin-A4,Inverse variance weighted,5,1.07 [0.86-1.32],0.55196903695096,trans
Chapter VI Diseases of the nervous system,FALLS,DSG2,Desmoglein-2,Inverse variance weighted,5,0.94 [0.78-1.14],0.552517330569073,trans
Chapter VI Diseases of the nervous system,FALLS,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,5,1.05 [0.88-1.26],0.555955154891171,trans
Chapter VI Diseases of the nervous system,FALLS,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,5,0.91 [0.66-1.25],0.556392167939054,trans
Chapter VI Diseases of the nervous system,FALLS,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,5,0.91 [0.67-1.24],0.557006894144838,trans
Chapter VI Diseases of the nervous system,FALLS,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,5,0.93 [0.74-1.18],0.562674038160907,trans
Chapter VI Diseases of the nervous system,FALLS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,5,1.06 [0.88-1.28],0.563220886354973,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,5,1.06 [0.87-1.28],0.564749222429793,trans
Chapter VI Diseases of the nervous system,FALLS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,5,1.05 [0.88-1.25],0.564889904879747,trans
Chapter VI Diseases of the nervous system,FALLS,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,5,1.06 [0.87-1.28],0.565902208721104,trans
Chapter VI Diseases of the nervous system,FALLS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,5,0.94 [0.77-1.15],0.56802477433813,trans
Chapter VI Diseases of the nervous system,FALLS,IL32,Interleukin-32,Inverse variance weighted,5,0.95 [0.78-1.15],0.568689891039034,trans
Chapter VI Diseases of the nervous system,FALLS,LAYN,Layilin,Inverse variance weighted,5,1.06 [0.88-1.27],0.568711654325901,trans
Chapter VI Diseases of the nervous system,FALLS,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,5,0.93 [0.72-1.2],0.57384295321996,trans
Chapter VI Diseases of the nervous system,FALLS,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,5,1.05 [0.88-1.27],0.576883887491056,trans
Chapter VI Diseases of the nervous system,FALLS,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.94 [0.77-1.15],0.577317510023747,trans
Chapter VI Diseases of the nervous system,FALLS,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,5,0.95 [0.78-1.15],0.578883702036928,trans
Chapter VI Diseases of the nervous system,FALLS,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,5,0.95 [0.78-1.15],0.581548994473097,trans
Chapter VI Diseases of the nervous system,FALLS,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,5,1.06 [0.87-1.28],0.582380243703864,trans
Chapter VI Diseases of the nervous system,FALLS,RNASE4,Ribonuclease 4,Inverse variance weighted,5,0.95 [0.78-1.15],0.583867328546699,trans
Chapter VI Diseases of the nervous system,FALLS,LGALS9,Galectin-9,Inverse variance weighted,5,1.08 [0.82-1.41],0.58787655242919,trans
Chapter VI Diseases of the nervous system,FALLS,CALCA,Calcitonin,Inverse variance weighted,5,1.05 [0.89-1.23],0.591420374889548,trans
Chapter VI Diseases of the nervous system,FALLS,LY96,Lymphocyte antigen 96,Inverse variance weighted,5,0.92 [0.69-1.24],0.591720955527867,trans
Chapter VI Diseases of the nervous system,FALLS,CD7,T-cell antigen CD7,Inverse variance weighted,5,1.05 [0.87-1.28],0.594708027514189,trans
Chapter VI Diseases of the nervous system,FALLS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,5,0.93 [0.71-1.21],0.596735974085725,trans
Chapter VI Diseases of the nervous system,FALLS,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,5,1.06 [0.85-1.32],0.59821521378181,trans
Chapter VI Diseases of the nervous system,FALLS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,5,1.05 [0.87-1.26],0.598824273755285,trans
Chapter VI Diseases of the nervous system,FALLS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,5,1.05 [0.88-1.26],0.602139173183274,trans
Chapter VI Diseases of the nervous system,FALLS,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,5,1.05 [0.87-1.26],0.602332089118798,trans
Chapter VI Diseases of the nervous system,FALLS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,5,0.96 [0.82-1.13],0.603738369728099,trans
Chapter VI Diseases of the nervous system,FALLS,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [0.86-1.28],0.60501755754766,trans
Chapter VI Diseases of the nervous system,FALLS,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.95 [0.78-1.16],0.60589676781477,trans
Chapter VI Diseases of the nervous system,FALLS,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,5,1.06 [0.84-1.35],0.610482768629707,trans
Chapter VI Diseases of the nervous system,FALLS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.95 [0.78-1.16],0.610783920498472,trans
Chapter VI Diseases of the nervous system,FALLS,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.06 [0.84-1.35],0.612579777234388,trans
Chapter VI Diseases of the nervous system,FALLS,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,5,0.92 [0.67-1.27],0.614562351324415,trans
Chapter VI Diseases of the nervous system,FALLS,ELN,Elastin,Inverse variance weighted,5,0.96 [0.83-1.12],0.620947427853024,trans
Chapter VI Diseases of the nervous system,FALLS,IL17C,Interleukin-17C,Inverse variance weighted,5,1.05 [0.86-1.28],0.621711888394136,trans
Chapter VI Diseases of the nervous system,FALLS,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,5,1.05 [0.87-1.26],0.624763123360083,trans
Chapter VI Diseases of the nervous system,FALLS,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,5,1.09 [0.78-1.52],0.625110815415155,trans
Chapter VI Diseases of the nervous system,FALLS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,5,0.94 [0.72-1.22],0.625435431612719,trans
Chapter VI Diseases of the nervous system,FALLS,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,5,0.95 [0.79-1.16],0.627660489304802,trans
Chapter VI Diseases of the nervous system,FALLS,MDK,Midkine,Inverse variance weighted,5,1.06 [0.84-1.33],0.628399809428438,trans
Chapter VI Diseases of the nervous system,FALLS,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,5,0.95 [0.78-1.16],0.629142262158602,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,5,0.95 [0.77-1.18],0.632290301084409,trans
Chapter VI Diseases of the nervous system,FALLS,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,5,0.96 [0.8-1.15],0.633712906052557,trans
Chapter VI Diseases of the nervous system,FALLS,KLK4,Kallikrein-4,Inverse variance weighted,5,1.06 [0.83-1.35],0.636737215159429,trans
Chapter VI Diseases of the nervous system,FALLS,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,5,0.96 [0.79-1.15],0.639450956994665,trans
Chapter VI Diseases of the nervous system,FALLS,MYL3,Myosin light chain 3,Inverse variance weighted,5,0.95 [0.75-1.19],0.639715145085378,trans
Chapter VI Diseases of the nervous system,FALLS,MSTN,Growth/differentiation factor 8,Inverse variance weighted,5,0.95 [0.75-1.19],0.639976026517102,trans
Chapter VI Diseases of the nervous system,FALLS,RNASE6,Ribonuclease K6,Inverse variance weighted,5,1.04 [0.87-1.25],0.640876686040234,trans
Chapter VI Diseases of the nervous system,FALLS,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,5,1.05 [0.86-1.28],0.64271162159668,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,5,0.96 [0.8-1.15],0.642989376171024,trans
Chapter VI Diseases of the nervous system,FALLS,PGF,Placenta growth factor,Inverse variance weighted,5,0.96 [0.8-1.14],0.643506786380939,trans
Chapter VI Diseases of the nervous system,FALLS,AGRN,Agrin,Inverse variance weighted,5,1.05 [0.87-1.26],0.643721922969364,trans
Chapter VI Diseases of the nervous system,FALLS,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,5,1.06 [0.84-1.33],0.644569381450226,trans
Chapter VI Diseases of the nervous system,FALLS,LGALS3,Galectin-3,Inverse variance weighted,5,1.05 [0.86-1.26],0.644701582777826,trans
Chapter VI Diseases of the nervous system,FALLS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,5,1.04 [0.87-1.26],0.646566464428976,trans
Chapter VI Diseases of the nervous system,FALLS,TCN2,Transcobalamin-2,Inverse variance weighted,5,1.04 [0.88-1.23],0.648253345369796,trans
Chapter VI Diseases of the nervous system,FALLS,REN,Renin,Inverse variance weighted,5,1.06 [0.84-1.33],0.649041768584853,trans
Chapter VI Diseases of the nervous system,FALLS,RSPO3,R-spondin-3,Inverse variance weighted,5,1.06 [0.83-1.36],0.649464572096017,trans
Chapter VI Diseases of the nervous system,FALLS,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,5,1.04 [0.86-1.26],0.650679152284652,trans
Chapter VI Diseases of the nervous system,FALLS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,5,0.96 [0.79-1.16],0.651053626551211,trans
Chapter VI Diseases of the nervous system,FALLS,IFNL1,Interferon lambda-1,Inverse variance weighted,5,1.05 [0.85-1.28],0.651552073300259,trans
Chapter VI Diseases of the nervous system,FALLS,CAPG,Macrophage-capping protein,Inverse variance weighted,5,0.97 [0.83-1.13],0.652978594837982,trans
Chapter VI Diseases of the nervous system,FALLS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,5,0.96 [0.79-1.16],0.653632710976599,trans
Chapter VI Diseases of the nervous system,FALLS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,5,1.06 [0.83-1.35],0.65436930802025,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,5,0.96 [0.8-1.15],0.654550687322961,trans
Chapter VI Diseases of the nervous system,FALLS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.96 [0.79-1.16],0.656715137715005,trans
Chapter VI Diseases of the nervous system,FALLS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,5,1.04 [0.88-1.23],0.658175333168114,trans
Chapter VI Diseases of the nervous system,FALLS,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,5,0.94 [0.72-1.23],0.659958200868046,trans
Chapter VI Diseases of the nervous system,FALLS,IL19,Interleukin-19,Inverse variance weighted,5,0.96 [0.79-1.16],0.66124993261148,trans
Chapter VI Diseases of the nervous system,FALLS,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.06 [0.82-1.36],0.663541736661633,trans
Chapter VI Diseases of the nervous system,FALLS,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,5,1.04 [0.86-1.26],0.663875738113316,trans
Chapter VI Diseases of the nervous system,FALLS,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,5,1.04 [0.86-1.27],0.665116490907544,trans
Chapter VI Diseases of the nervous system,FALLS,POF1B,Protein POF1B,Inverse variance weighted,5,1.05 [0.85-1.28],0.665139903821535,trans
Chapter VI Diseases of the nervous system,FALLS,SEPTIN8,Septin-8,Inverse variance weighted,5,0.96 [0.79-1.16],0.668180593709787,trans
Chapter VI Diseases of the nervous system,FALLS,SDC1,Syndecan-1,Inverse variance weighted,5,1.04 [0.86-1.27],0.669130821480572,trans
Chapter VI Diseases of the nervous system,FALLS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,5,0.93 [0.69-1.28],0.670829199102799,trans
Chapter VI Diseases of the nervous system,FALLS,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,5,0.96 [0.78-1.17],0.671697758270131,trans
Chapter VI Diseases of the nervous system,FALLS,OGN,Mimecan,Inverse variance weighted,5,0.96 [0.82-1.14],0.673581653203234,trans
Chapter VI Diseases of the nervous system,FALLS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.95 [0.74-1.21],0.67430301600836,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP1,Insulin-like growth factor-binding protein 1,Inverse variance weighted,5,0.96 [0.79-1.17],0.676536064749765,trans
Chapter VI Diseases of the nervous system,FALLS,KLK11,Kallikrein-11,Inverse variance weighted,5,1.04 [0.86-1.26],0.678883550775131,trans
Chapter VI Diseases of the nervous system,FALLS,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,5,0.96 [0.8-1.15],0.679813379978144,trans
Chapter VI Diseases of the nervous system,FALLS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.96 [0.81-1.15],0.681881571594513,trans
Chapter VI Diseases of the nervous system,FALLS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,5,0.96 [0.8-1.15],0.6824852848447,trans
Chapter VI Diseases of the nervous system,FALLS,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,5,0.95 [0.76-1.2],0.682712867908861,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,5,1.07 [0.78-1.45],0.684438165784626,trans
Chapter VI Diseases of the nervous system,FALLS,COLEC12,Collectin-12,Inverse variance weighted,5,1.05 [0.83-1.33],0.685375918468534,trans
Chapter VI Diseases of the nervous system,FALLS,SLAMF8,SLAM family member 8,Inverse variance weighted,5,1.05 [0.82-1.36],0.685443631806036,trans
Chapter VI Diseases of the nervous system,FALLS,B2M,Beta-2-microglobulin,Inverse variance weighted,5,0.96 [0.79-1.17],0.687064748068346,trans
Chapter VI Diseases of the nervous system,FALLS,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,5,0.94 [0.68-1.29],0.688563332896236,trans
Chapter VI Diseases of the nervous system,FALLS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,5,1.04 [0.86-1.25],0.694014980514655,trans
Chapter VI Diseases of the nervous system,FALLS,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.95 [0.72-1.24],0.694218746990364,trans
Chapter VI Diseases of the nervous system,FALLS,PRG2,Bone marrow proteoglycan,Inverse variance weighted,5,1.04 [0.86-1.26],0.694751760752312,trans
Chapter VI Diseases of the nervous system,FALLS,EFNA1,Ephrin-A1,Inverse variance weighted,5,1.04 [0.84-1.29],0.705760668007449,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,1.04 [0.86-1.26],0.706320149093077,trans
Chapter VI Diseases of the nervous system,FALLS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,5,1.04 [0.86-1.26],0.707670249867851,trans
Chapter VI Diseases of the nervous system,FALLS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.93 [0.66-1.33],0.708526282007801,trans
Chapter VI Diseases of the nervous system,FALLS,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,5,1.05 [0.82-1.34],0.71001704759018,trans
Chapter VI Diseases of the nervous system,FALLS,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,5,1.04 [0.85-1.26],0.711477622783867,trans
Chapter VI Diseases of the nervous system,FALLS,DSC2,Desmocollin-2,Inverse variance weighted,5,0.96 [0.8-1.17],0.713452623976848,trans
Chapter VI Diseases of the nervous system,FALLS,PSAP,Prosaposin,Inverse variance weighted,5,1.06 [0.79-1.42],0.714349429614301,trans
Chapter VI Diseases of the nervous system,FALLS,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,5,1.03 [0.86-1.25],0.719239083723028,trans
Chapter VI Diseases of the nervous system,FALLS,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,5,0.97 [0.8-1.17],0.72014786905146,trans
Chapter VI Diseases of the nervous system,FALLS,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,5,1.03 [0.86-1.25],0.720728040586464,trans
Chapter VI Diseases of the nervous system,FALLS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,5,0.96 [0.75-1.22],0.721697960078488,trans
Chapter VI Diseases of the nervous system,FALLS,CKB,Creatine kinase B-type,Inverse variance weighted,5,0.97 [0.79-1.17],0.721817294187382,trans
Chapter VI Diseases of the nervous system,FALLS,SPP1,Osteopontin,Inverse variance weighted,5,1.06 [0.76-1.5],0.722922984548876,trans
Chapter VI Diseases of the nervous system,FALLS,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.05 [0.8-1.38],0.726264039487943,trans
Chapter VI Diseases of the nervous system,FALLS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.96 [0.75-1.23],0.726522558925884,trans
Chapter VI Diseases of the nervous system,FALLS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,5,0.97 [0.8-1.17],0.726723819642804,trans
Chapter VI Diseases of the nervous system,FALLS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,5,0.96 [0.76-1.21],0.72722002255901,trans
Chapter VI Diseases of the nervous system,FALLS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,5,0.96 [0.74-1.23],0.727508599666936,trans
Chapter VI Diseases of the nervous system,FALLS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,5,1.04 [0.85-1.26],0.72880380231522,trans
Chapter VI Diseases of the nervous system,FALLS,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,5,1.03 [0.86-1.25],0.7291062815454,trans
Chapter VI Diseases of the nervous system,FALLS,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,5,1.04 [0.84-1.28],0.73021037125452,trans
Chapter VI Diseases of the nervous system,FALLS,NECTIN4,Nectin-4,Inverse variance weighted,5,0.97 [0.8-1.17],0.731071491999748,trans
Chapter VI Diseases of the nervous system,FALLS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,5,1.04 [0.84-1.27],0.731115879348747,trans
Chapter VI Diseases of the nervous system,FALLS,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,5,1.03 [0.85-1.26],0.731249343255093,trans
Chapter VI Diseases of the nervous system,FALLS,MUC13,Mucin-13,Inverse variance weighted,5,0.97 [0.79-1.18],0.733336335071314,trans
Chapter VI Diseases of the nervous system,FALLS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,5,0.97 [0.79-1.18],0.734670590651656,trans
Chapter VI Diseases of the nervous system,FALLS,CTSD,Cathepsin D,Inverse variance weighted,5,1.03 [0.85-1.25],0.735345666994479,trans
Chapter VI Diseases of the nervous system,FALLS,ULBP2,UL16-binding protein 2,Inverse variance weighted,5,1.03 [0.86-1.24],0.737542991282464,trans
Chapter VI Diseases of the nervous system,FALLS,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,5,0.96 [0.78-1.2],0.73845664163194,trans
Chapter VI Diseases of the nervous system,FALLS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,5,0.97 [0.79-1.18],0.738480429962496,trans
Chapter VI Diseases of the nervous system,FALLS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,5,0.97 [0.8-1.17],0.738751584490751,trans
Chapter VI Diseases of the nervous system,FALLS,GHR,Growth hormone receptor,Inverse variance weighted,5,1.03 [0.86-1.24],0.740328082445425,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,5,1.03 [0.85-1.25],0.741453529814629,trans
Chapter VI Diseases of the nervous system,FALLS,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,5,0.97 [0.8-1.17],0.745491999208271,trans
Chapter VI Diseases of the nervous system,FALLS,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,5,1.03 [0.87-1.22],0.747155592581772,trans
Chapter VI Diseases of the nervous system,FALLS,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.96 [0.77-1.2],0.747493963889164,trans
Chapter VI Diseases of the nervous system,FALLS,DLL1,Delta-like protein 1,Inverse variance weighted,5,1.03 [0.85-1.25],0.75155316592495,trans
Chapter VI Diseases of the nervous system,FALLS,EDN1,Endothelin-1,Inverse variance weighted,5,1.03 [0.84-1.27],0.754880382317271,trans
Chapter VI Diseases of the nervous system,FALLS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,5,1.03 [0.85-1.25],0.755763739603276,trans
Chapter VI Diseases of the nervous system,FALLS,CA12,Carbonic anhydrase 12,Inverse variance weighted,5,1.04 [0.83-1.29],0.756119496841897,trans
Chapter VI Diseases of the nervous system,FALLS,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,5,0.97 [0.79-1.18],0.756134531379935,trans
Chapter VI Diseases of the nervous system,FALLS,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,5,0.97 [0.8-1.18],0.758867346298196,trans
Chapter VI Diseases of the nervous system,FALLS,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,5,1.03 [0.83-1.28],0.760353370624383,trans
Chapter VI Diseases of the nervous system,FALLS,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,5,1.03 [0.86-1.23],0.762466101418469,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,5,1.05 [0.77-1.44],0.764014609528893,trans
Chapter VI Diseases of the nervous system,FALLS,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,5,1.04 [0.81-1.33],0.768377082462519,trans
Chapter VI Diseases of the nervous system,FALLS,GRN,Progranulin,Inverse variance weighted,5,1.03 [0.83-1.29],0.768715368372636,trans
Chapter VI Diseases of the nervous system,FALLS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,5,1.04 [0.82-1.31],0.771739441292367,trans
Chapter VI Diseases of the nervous system,FALLS,AFM,Afamin,Inverse variance weighted,5,1.03 [0.85-1.25],0.772256358649743,trans
Chapter VI Diseases of the nervous system,FALLS,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,5,0.97 [0.8-1.18],0.775864737059646,trans
Chapter VI Diseases of the nervous system,FALLS,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,5,0.94 [0.62-1.43],0.779188356947467,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC3B,Tetranectin,Inverse variance weighted,5,0.97 [0.8-1.18],0.780503905106586,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,5,0.97 [0.81-1.18],0.780648165143475,trans
Chapter VI Diseases of the nervous system,FALLS,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,5,1.03 [0.81-1.31],0.781552908074873,trans
Chapter VI Diseases of the nervous system,FALLS,IL15,Interleukin-15,Inverse variance weighted,5,0.97 [0.76-1.23],0.785562463917878,trans
Chapter VI Diseases of the nervous system,FALLS,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,5,1.03 [0.84-1.25],0.789285614001807,trans
Chapter VI Diseases of the nervous system,FALLS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,5,1.05 [0.75-1.45],0.790298162373606,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,5,1.02 [0.86-1.22],0.791564956565405,trans
Chapter VI Diseases of the nervous system,FALLS,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,5,0.97 [0.8-1.19],0.791966794427219,trans
Chapter VI Diseases of the nervous system,FALLS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,5,1.03 [0.83-1.28],0.797182816694586,trans
Chapter VI Diseases of the nervous system,FALLS,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,5,1.04 [0.77-1.4],0.79738840591714,trans
Chapter VI Diseases of the nervous system,FALLS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,5,0.98 [0.81-1.18],0.799441484366978,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.03 [0.84-1.25],0.800909357752295,trans
Chapter VI Diseases of the nervous system,FALLS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,5,0.98 [0.8-1.19],0.802535846830388,trans
Chapter VI Diseases of the nervous system,FALLS,ITGA11,Integrin alpha-11,Inverse variance weighted,5,1.02 [0.84-1.24],0.806434704466193,trans
Chapter VI Diseases of the nervous system,FALLS,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,5,1.02 [0.85-1.23],0.80880308342189,trans
Chapter VI Diseases of the nervous system,FALLS,SNCG,Gamma-synuclein,Inverse variance weighted,5,1.02 [0.87-1.19],0.811118471287748,trans
Chapter VI Diseases of the nervous system,FALLS,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,5,0.96 [0.7-1.32],0.811896362337507,trans
Chapter VI Diseases of the nervous system,FALLS,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.04 [0.76-1.42],0.812862148830716,trans
Chapter VI Diseases of the nervous system,FALLS,CDH1,Cadherin-1,Inverse variance weighted,5,1.02 [0.84-1.25],0.813478627600306,trans
Chapter VI Diseases of the nervous system,FALLS,GSN,Gelsolin,Inverse variance weighted,5,0.97 [0.72-1.29],0.813512957952957,trans
Chapter VI Diseases of the nervous system,FALLS,CD48,CD48 antigen,Inverse variance weighted,5,0.97 [0.78-1.22],0.814492200807808,trans
Chapter VI Diseases of the nervous system,FALLS,ADM,Pro-adrenomedullin,Inverse variance weighted,5,1.03 [0.83-1.27],0.816551473403147,trans
Chapter VI Diseases of the nervous system,FALLS,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,5,0.98 [0.81-1.18],0.816740123339614,trans
Chapter VI Diseases of the nervous system,FALLS,TNR,Tenascin-R,Inverse variance weighted,5,0.98 [0.81-1.18],0.817995464140195,trans
Chapter VI Diseases of the nervous system,FALLS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,5,0.97 [0.78-1.22],0.818315950946419,trans
Chapter VI Diseases of the nervous system,FALLS,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,5,1.03 [0.83-1.27],0.81866307601015,trans
Chapter VI Diseases of the nervous system,FALLS,CD27,CD27 antigen,Inverse variance weighted,5,1.03 [0.78-1.37],0.820499260358455,trans
Chapter VI Diseases of the nervous system,FALLS,PRTN3,Myeloblastin,Inverse variance weighted,5,0.98 [0.81-1.18],0.822083297491583,trans
Chapter VI Diseases of the nervous system,FALLS,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,5,1.02 [0.85-1.22],0.824322789556514,trans
Chapter VI Diseases of the nervous system,FALLS,NRP1,Neuropilin-1,Inverse variance weighted,5,1.02 [0.84-1.24],0.824369433312362,trans
Chapter VI Diseases of the nervous system,FALLS,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,5,1.03 [0.81-1.31],0.825527492290347,trans
Chapter VI Diseases of the nervous system,FALLS,SPON2,Spondin-2,Inverse variance weighted,5,1.02 [0.84-1.24],0.829901811325588,trans
Chapter VI Diseases of the nervous system,FALLS,FAM3D,Protein FAM3D,Inverse variance weighted,5,0.98 [0.83-1.16],0.830013418702429,trans
Chapter VI Diseases of the nervous system,FALLS,CST3,Cystatin-C,Inverse variance weighted,5,0.98 [0.82-1.18],0.831873681451705,trans
Chapter VI Diseases of the nervous system,FALLS,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,5,1.02 [0.84-1.24],0.832195049657178,trans
Chapter VI Diseases of the nervous system,FALLS,ADA2,Adenosine deaminase 2,Inverse variance weighted,5,0.97 [0.69-1.34],0.832845373199358,trans
Chapter VI Diseases of the nervous system,FALLS,CHGB,Secretogranin-1,Inverse variance weighted,5,0.98 [0.82-1.18],0.832966773674205,trans
Chapter VI Diseases of the nervous system,FALLS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,5,1.02 [0.85-1.23],0.8381143399175,trans
Chapter VI Diseases of the nervous system,FALLS,STC1,Stanniocalcin-1,Inverse variance weighted,5,0.98 [0.81-1.19],0.83815808630832,trans
Chapter VI Diseases of the nervous system,FALLS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,5,1.02 [0.85-1.23],0.845998401893744,trans
Chapter VI Diseases of the nervous system,FALLS,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,5,0.98 [0.81-1.19],0.849590713226285,trans
Chapter VI Diseases of the nervous system,FALLS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,5,0.98 [0.81-1.19],0.849706263240261,trans
Chapter VI Diseases of the nervous system,FALLS,MATN2,Matrilin-2,Inverse variance weighted,5,0.98 [0.82-1.18],0.851194967900203,trans
Chapter VI Diseases of the nervous system,FALLS,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",Inverse variance weighted,5,1.02 [0.79-1.32],0.854793725198365,trans
Chapter VI Diseases of the nervous system,FALLS,BRK1,Protein BRICK1,Inverse variance weighted,5,0.98 [0.8-1.2],0.855603013234348,trans
Chapter VI Diseases of the nervous system,FALLS,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,5,1.02 [0.83-1.25],0.85800222963211,trans
Chapter VI Diseases of the nervous system,FALLS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,5,0.98 [0.81-1.19],0.860545488455261,trans
Chapter VI Diseases of the nervous system,FALLS,CCL20,C-C motif chemokine 20,Inverse variance weighted,5,1.02 [0.84-1.24],0.862489588198265,trans
Chapter VI Diseases of the nervous system,FALLS,INHBB,Inhibin beta B chain,Inverse variance weighted,5,0.98 [0.75-1.27],0.863783145551417,trans
Chapter VI Diseases of the nervous system,FALLS,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,5,0.98 [0.78-1.23],0.865496035484378,trans
Chapter VI Diseases of the nervous system,FALLS,RETN,Resistin,Inverse variance weighted,5,1.02 [0.82-1.27],0.866103997313919,trans
Chapter VI Diseases of the nervous system,FALLS,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,5,0.98 [0.79-1.22],0.867927746442859,trans
Chapter VI Diseases of the nervous system,FALLS,SLAMF7,SLAM family member 7,Inverse variance weighted,5,1.02 [0.8-1.31],0.868460117742936,trans
Chapter VI Diseases of the nervous system,FALLS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,5,1.02 [0.8-1.29],0.868563733297343,trans
Chapter VI Diseases of the nervous system,FALLS,AMBP,Protein AMBP,Inverse variance weighted,5,0.98 [0.82-1.19],0.870452734620447,trans
Chapter VI Diseases of the nervous system,FALLS,CCL15,C-C motif chemokine 15,Inverse variance weighted,5,1.01 [0.85-1.2],0.870921475566751,trans
Chapter VI Diseases of the nervous system,FALLS,PRSS8,Prostasin,Inverse variance weighted,5,1.02 [0.84-1.22],0.871340527456297,trans
Chapter VI Diseases of the nervous system,FALLS,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,5,0.98 [0.76-1.27],0.873999359395577,trans
Chapter VI Diseases of the nervous system,FALLS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,5,0.99 [0.82-1.19],0.874018077352207,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.02 [0.81-1.29],0.87518465869369,trans
Chapter VI Diseases of the nervous system,FALLS,PALM2,Paralemmin-2,Inverse variance weighted,5,0.98 [0.81-1.19],0.875512945744042,trans
Chapter VI Diseases of the nervous system,FALLS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,5,1.02 [0.77-1.36],0.87650023418214,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,5,0.98 [0.81-1.2],0.876868637601017,trans
Chapter VI Diseases of the nervous system,FALLS,SHBG,Sex hormone-binding globulin,Inverse variance weighted,5,1.01 [0.85-1.21],0.876936820122935,trans
Chapter VI Diseases of the nervous system,FALLS,SPON1,Spondin-1,Inverse variance weighted,5,1.01 [0.84-1.22],0.877543293195038,trans
Chapter VI Diseases of the nervous system,FALLS,MEP1B,Meprin A subunit beta,Inverse variance weighted,5,1.01 [0.89-1.15],0.878979867316158,trans
Chapter VI Diseases of the nervous system,FALLS,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,5,0.98 [0.78-1.24],0.87984434358939,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.01 [0.84-1.23],0.880303453257717,trans
Chapter VI Diseases of the nervous system,FALLS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,5,1.01 [0.84-1.23],0.883948752753338,trans
Chapter VI Diseases of the nervous system,FALLS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,5,1.01 [0.85-1.21],0.88714894844905,trans
Chapter VI Diseases of the nervous system,FALLS,NECTIN2,Nectin-2,Inverse variance weighted,5,0.99 [0.81-1.2],0.88772763878698,trans
Chapter VI Diseases of the nervous system,FALLS,PTN,Pleiotrophin,Inverse variance weighted,5,0.99 [0.81-1.19],0.888628662358422,trans
Chapter VI Diseases of the nervous system,FALLS,GAST,Gastrin,Inverse variance weighted,5,0.97 [0.61-1.55],0.891605336516258,trans
Chapter VI Diseases of the nervous system,FALLS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,5,0.99 [0.82-1.18],0.891736852474675,trans
Chapter VI Diseases of the nervous system,FALLS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,5,1.01 [0.84-1.23],0.892191448265936,trans
Chapter VI Diseases of the nervous system,FALLS,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,5,1.01 [0.85-1.21],0.894393433698216,trans
Chapter VI Diseases of the nervous system,FALLS,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,5,0.98 [0.77-1.26],0.899832849391489,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,5,0.99 [0.82-1.2],0.906606256327602,trans
Chapter VI Diseases of the nervous system,FALLS,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,5,1.01 [0.85-1.19],0.908482832601631,trans
Chapter VI Diseases of the nervous system,FALLS,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,5,0.99 [0.81-1.2],0.912993760927856,trans
Chapter VI Diseases of the nervous system,FALLS,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,5,1.01 [0.85-1.2],0.913372248647093,trans
Chapter VI Diseases of the nervous system,FALLS,BSG,Basigin,Inverse variance weighted,5,1.01 [0.83-1.22],0.919628888729151,trans
Chapter VI Diseases of the nervous system,FALLS,PENK,Proenkephalin-A,Inverse variance weighted,5,0.99 [0.8-1.23],0.919851923473223,trans
Chapter VI Diseases of the nervous system,FALLS,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,5,1.01 [0.82-1.24],0.920421532737722,trans
Chapter VI Diseases of the nervous system,FALLS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,5,0.99 [0.82-1.19],0.921010499508029,trans
Chapter VI Diseases of the nervous system,FALLS,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,5,1.01 [0.82-1.24],0.92321772668049,trans
Chapter VI Diseases of the nervous system,FALLS,MMP12,Macrophage metalloelastase,Inverse variance weighted,5,1.01 [0.85-1.2],0.925040868319187,trans
Chapter VI Diseases of the nervous system,FALLS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,5,1.01 [0.83-1.22],0.925435934389721,trans
Chapter VI Diseases of the nervous system,FALLS,CD99,CD99 antigen,Inverse variance weighted,5,0.99 [0.84-1.18],0.92547165968979,trans
Chapter VI Diseases of the nervous system,FALLS,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,5,1.01 [0.76-1.36],0.926276998963566,trans
Chapter VI Diseases of the nervous system,FALLS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.01 [0.85-1.2],0.92673038805019,trans
Chapter VI Diseases of the nervous system,FALLS,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,5,0.99 [0.83-1.18],0.928322431480489,trans
Chapter VI Diseases of the nervous system,FALLS,CPM,Carboxypeptidase M,Inverse variance weighted,5,0.99 [0.82-1.2],0.929850874274253,trans
Chapter VI Diseases of the nervous system,FALLS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,5,0.99 [0.77-1.27],0.93412714519877,trans
Chapter VI Diseases of the nervous system,FALLS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,5,1.01 [0.74-1.4],0.937733097160143,trans
Chapter VI Diseases of the nervous system,FALLS,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,5,0.99 [0.82-1.21],0.938647789198661,trans
Chapter VI Diseases of the nervous system,FALLS,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,5,1.01 [0.83-1.22],0.940189974347656,trans
Chapter VI Diseases of the nervous system,FALLS,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,5,0.99 [0.79-1.25],0.941102282703735,trans
Chapter VI Diseases of the nervous system,FALLS,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,5,1.01 [0.71-1.45],0.945279239512007,trans
Chapter VI Diseases of the nervous system,FALLS,TFF1,Trefoil factor 1,Inverse variance weighted,5,1.01 [0.74-1.38],0.946784047483371,trans
Chapter VI Diseases of the nervous system,FALLS,FBLN2,Fibulin-2,Inverse variance weighted,5,1.01 [0.8-1.27],0.94691538319436,trans
Chapter VI Diseases of the nervous system,FALLS,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,5,1.01 [0.85-1.19],0.948747086694841,trans
Chapter VI Diseases of the nervous system,FALLS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,5,1.01 [0.81-1.25],0.95161716765339,trans
Chapter VI Diseases of the nervous system,FALLS,SIGLEC1,Sialoadhesin,Inverse variance weighted,5,0.99 [0.81-1.22],0.952353254114718,trans
Chapter VI Diseases of the nervous system,FALLS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,5,1.01 [0.83-1.22],0.955720111687148,trans
Chapter VI Diseases of the nervous system,FALLS,CD302,CD302 antigen,Inverse variance weighted,5,1.01 [0.79-1.28],0.956521037075196,trans
Chapter VI Diseases of the nervous system,FALLS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,5,1.01 [0.77-1.31],0.956529161781049,trans
Chapter VI Diseases of the nervous system,FALLS,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,5,1.01 [0.82-1.23],0.958663607390456,trans
Chapter VI Diseases of the nervous system,FALLS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1 [0.83-1.2],0.958801569355735,trans
Chapter VI Diseases of the nervous system,FALLS,UMOD,Uromodulin,Inverse variance weighted,5,0.99 [0.82-1.21],0.959215959605937,trans
Chapter VI Diseases of the nervous system,FALLS,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,5,1 [0.83-1.21],0.960711786920273,trans
Chapter VI Diseases of the nervous system,FALLS,CSTB,Cystatin-B,Inverse variance weighted,5,1 [0.84-1.21],0.963182229312848,trans
Chapter VI Diseases of the nervous system,FALLS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,1 [0.83-1.22],0.963345754337102,trans
Chapter VI Diseases of the nervous system,FALLS,CFD,Complement factor D,Inverse variance weighted,5,1 [0.82-1.21],0.963918109605724,trans
Chapter VI Diseases of the nervous system,FALLS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,5,1 [0.82-1.23],0.964532560958886,trans
Chapter VI Diseases of the nervous system,FALLS,FSTL1,Follistatin-related protein 1,Inverse variance weighted,5,1 [0.81-1.22],0.966310952581855,trans
Chapter VI Diseases of the nervous system,FALLS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,5,1 [0.79-1.25],0.967809635555116,trans
Chapter VI Diseases of the nervous system,FALLS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,5,1 [0.8-1.24],0.97280290574641,trans
Chapter VI Diseases of the nervous system,FALLS,CLMP,CXADR-like membrane protein,Inverse variance weighted,5,1 [0.84-1.2],0.974722568814108,trans
Chapter VI Diseases of the nervous system,FALLS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1 [0.83-1.22],0.977700120840447,trans
Chapter VI Diseases of the nervous system,FALLS,CBLN4,Cerebellin-4,Inverse variance weighted,5,1 [0.79-1.27],0.98370196209269,trans
Chapter VI Diseases of the nervous system,FALLS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,5,1 [0.83-1.21],0.984554204223732,trans
Chapter VI Diseases of the nervous system,FALLS,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,5,1 [0.78-1.28],0.98484042380242,trans
Chapter VI Diseases of the nervous system,FALLS,CCL3,C-C motif chemokine 3,Inverse variance weighted,5,1 [0.77-1.31],0.98602927838811,trans
Chapter VI Diseases of the nervous system,FALLS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,5,1 [0.83-1.21],0.991053913794848,trans
Chapter VI Diseases of the nervous system,FALLS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1 [0.8-1.25],0.992273143921307,trans
Chapter VI Diseases of the nervous system,FALLS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,5,1 [0.82-1.22],0.992466804867173,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,5,1 [0.83-1.2],0.99384855388542,trans
Chapter VI Diseases of the nervous system,FALLS,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,5,1 [0.75-1.34],0.994497246611033,trans
Chapter VI Diseases of the nervous system,FALLS,THBS2,Thrombospondin-2,Inverse variance weighted,5,1 [0.75-1.33],0.994788316205542,trans
Chapter VI Diseases of the nervous system,FALLS,GDF15,Growth/differentiation factor 15,Inverse variance weighted,5,1 [0.81-1.24],0.996135033970256,trans
Chapter VI Diseases of the nervous system,FALLS,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,5,1 [0.82-1.22],0.997553734796378,trans
